Home » Topics » BioWorld Science

BioWorld Science
RSS

Data from Metformin GR phase II trial reported by DepoMed

Aug. 9, 2001

Graffinity Pharmaceutical Design and Biosearch Italia form drug discovery alliance

Aug. 9, 2001

Replagal receives European approval for Fabry's disease

Aug. 9, 2001

Ascorbic acid enhances arsenic trioxide potency in MM cells

Aug. 9, 2001

AxyS describes new serine protease inhibitor design technology

Aug. 9, 2001

Simultaneous filing of a Common Technical Document for Amevive in the U.S. and Europe

Aug. 8, 2001

Researchers at Sankyo identify new MMP inhibitors

Aug. 8, 2001

Selective PDE5 inhibitors reported by scientists at Nippon Soda

Aug. 8, 2001

Taisho patents compounds for treating bone or neurological diseases

Aug. 8, 2001

Arizona State University scientists design new DNA reductive alkylating agents

Aug. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...